Advanced Enzyme Technologies Ltd (ADVENZYMES) Q4FY26 Management Mirror - Mar-2026 Qtr
Revenue & Segment Growth
Management introduced expectations for healthy FY27 growth across the human nutrition, animal nutrition, and bioprocessing segments in the Mar'26 Qtr, while prior quarters (Dec'25 Qtr and Sep'25 Qtr) had outlined and reaffirmed a continuous long-term double-digit revenue growth trajectory of 13% to 15% over the next three to five years. [Status: Initiated]
5 more themes on the ELITE plan.